Makoto Ito
Papers
1
Total Citations
6
H-Index
1
About
Makoto Ito is a radiation oncology researcher whose work centers on the optimization of ultrahypofractionated radiation therapy for prostate cancer, with a particular focus on comparative treatment planning methodologies. His most notable contribution examines the dosimetric differences between high-dose-rate brachytherapy (HDR-BT) and stereotactic body radiotherapy (SBRT) — including both robotic and conventional delivery platforms — providing clinicians with critical insights into which modality may offer superior target coverage and organ-at-risk sparing for individual patients. As ultrahypofractionation gains momentum in urological oncology due to its radiobiological advantages and patient convenience, Ito's comparative analyses serve as a practical reference point for treatment teams navigating an increasingly complex landscape of delivery options. His 2023 publication, which has already accumulated 6 citations within a short period, reflects growing community interest in evidence-based treatment selection for prostate cancer. Ito's research contributes meaningfully to the ongoing clinical conversation about personalizing radiation delivery, ultimately supporting efforts to maximize tumor control while minimizing toxicity for patients undergoing prostate cancer radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1